General MedicationsINJECTIONGeneric

SODIUM NITROPRUSSIDE

Standard Dose

50MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Max Dose

Refer to approved labeling

Primary Use

Marketing status: Discontinued

Summary

Approval overview SODIUM NITROPRUSSIDE is listed in Drugs@FDA under application 018581 (NDA).

Marketing status: Discontinued Active ingredient SODIUM NITROPRUSSIDE Form and strength INJECTABLE;INJECTION - 50MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor BAXTER HLTHCARE Submission history Latest submission status date: 1998-01-16 00:00:00.

Structured Monograph

Clinical summary

Approval overview SODIUM NITROPRUSSIDE is listed in Drugs@FDA under application 018581 (NDA). Marketing status: Discontinued Active ingredient SODIUM NITROPRUSSIDE Form and strength INJECTABLE;INJECTION - 50MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor BAXTER HLTHCARE Submission history Latest submission status date: 1998-01-16 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued

Interaction Notes

No interaction notes stored yet.